These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6309852

  • 1. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.
    Boon NA, Elliott JM, Grahame-Smith DG, St John-Green T, Stump K.
    J Auton Pharmacol; 1983 Jun; 3(2):89-95. PubMed ID: 6309852
    [Abstract] [Full Text] [Related]

  • 2. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ, Insel PA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2591-7. PubMed ID: 6291538
    [Abstract] [Full Text] [Related]

  • 3. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
    Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ.
    J Clin Invest; 1978 Feb 15; 61(2):395-402. PubMed ID: 23392
    [Abstract] [Full Text] [Related]

  • 4. The binding characteristics of [3H]-dihydroergocryptine on intact human platelets.
    Elliott JM, Grahame-Smith DG.
    Br J Pharmacol; 1982 May 15; 76(1):121-30. PubMed ID: 6805543
    [Abstract] [Full Text] [Related]

  • 5. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D.
    J Clin Invest; 1984 Sep 15; 74(3):1063-72. PubMed ID: 6088579
    [Abstract] [Full Text] [Related]

  • 6. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES, Addonizio VP, Shattil SJ.
    Am J Physiol; 1982 Jan 15; 242(1):H19-23. PubMed ID: 6277203
    [Abstract] [Full Text] [Related]

  • 7. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
    García-Sevilla JA, Hollingsworth PJ, Smnith CB.
    Eur J Pharmacol; 1981 Sep 24; 74(4):329-41. PubMed ID: 6271559
    [Abstract] [Full Text] [Related]

  • 8. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F, Cazenave JP.
    Thromb Haemost; 1985 Aug 30; 54(2):402-8. PubMed ID: 3001964
    [Abstract] [Full Text] [Related]

  • 9. The effects of monovalent and divalent cations on the alpha-adrenoceptor of intact human platelets.
    Elliott JM, Grahame-Smith DG.
    Br J Pharmacol; 1982 Oct 30; 77(2):277-83. PubMed ID: 6291686
    [Abstract] [Full Text] [Related]

  • 10. Binding of [3H]-dihydroergocryptine to alpha-adrenoceptors on intact human platelets [proceedings].
    Boullin DJ, Elliott JM.
    Br J Pharmacol; 1979 May 30; 66(1):89P-90P. PubMed ID: 222386
    [No Abstract] [Full Text] [Related]

  • 11. Platelet alpha 2 adrenoreceptors in chronic congestive heart failure.
    Weiss RJ, Tobes M, Wertz CE, Smith CB.
    Am J Cardiol; 1983 Jul 30; 52(1):101-5. PubMed ID: 6305182
    [Abstract] [Full Text] [Related]

  • 12. Differential labeling of platelet alpha 2 adrenoceptors by 3H dihydroergocryptine and 3H yohimbine in patients with myeloproliferative disorders.
    Swart SS, Wood JK, Barnett DB.
    Thromb Res; 1985 Dec 01; 40(5):623-9. PubMed ID: 3003960
    [Abstract] [Full Text] [Related]

  • 13. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
    Motulsky HJ, Shattil SJ, Insel PA.
    Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1562-70. PubMed ID: 6260094
    [No Abstract] [Full Text] [Related]

  • 14. Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.
    Carman-Krzan M.
    Arch Int Pharmacodyn Ther; 1980 Aug 31; 246(2):237-50. PubMed ID: 6254455
    [Abstract] [Full Text] [Related]

  • 15. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A.
    Biochim Biophys Acta; 1981 Aug 17; 676(2):148-54. PubMed ID: 6114754
    [Abstract] [Full Text] [Related]

  • 16. [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors.
    Cheung YD, Barnett DB, Nahorski SR.
    Eur J Pharmacol; 1982 Oct 15; 84(1-2):79-85. PubMed ID: 6291953
    [Abstract] [Full Text] [Related]

  • 17. alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.
    Tharp MD, Hoffman BB, Lefkowitz RJ.
    J Clin Endocrinol Metab; 1981 Apr 15; 52(4):709-14. PubMed ID: 6110673
    [Abstract] [Full Text] [Related]

  • 18. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P, Meyer P.
    Br J Pharmacol; 1981 May 15; 73(1):33-9. PubMed ID: 6269682
    [Abstract] [Full Text] [Related]

  • 19. Catecholamine binding to the alpha-adrenergic receptors of hamster adipocytes. Evidence that guanine nucleotides regulate this binding to the alpha 2-receptor subtype.
    Pecquery R, Giudicelli Y.
    Biochim Biophys Acta; 1982 Jan 12; 714(1):14-25. PubMed ID: 6275904
    [Abstract] [Full Text] [Related]

  • 20. Characterization of alpha 2-adrenoceptors on blood platelets from various species using 3H-yohimbine.
    Glusa E, Markwardt F.
    Haemostasis; 1983 Jan 12; 13(2):96-101. PubMed ID: 6307838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.